We studied the clinical isolates Enterococcus faecium NEF1, resistant to high levels of vancomycin (MIC, 512 g/ml) and teicoplanin (MIC, 64 g/ml); Enterococcus faecium BM4653 and BM4656 and Enterococcus avium BM4655, resistant to moderate levels of vancomycin (MIC, 32 g/ml) and to low levels of teicoplanin (MIC, 4 g/ml); and Enterococcus faecalis BM4654, moderately resistant to vancomycin (MIC, 16 g/ml) but susceptible to teicoplanin (MIC, 0.5 g/ml). (6,7,10,13,16,31), two E. faecalis strains (13), one Enterococcus gallinarum strain (8), and one Enterococcus raffinosus strain (37). Recently, the vanD operon was detected in a Ruminococcus sp., an anaerobic gram-positive bacterium from human bowel flora, suggesting a potential reservoir for vancomycin resistance genes in commensals of the digestive tract (17).VanD-type strains share various characteristics that distinguish them from VanA-and VanB-type enterococci. In particular, resistance to moderate levels of the two glycopeptides is constitutively expressed and is not transferable by conjugation to other enterococci (10,13,16,31). The organization of the vanD gene cluster, located exclusively in the chromosome, is similar to those of vanA and vanB (13,16